Qlife Holding AB
The answer first
Does Qlife Holding beat the market?
No, Qlife Holding has not beaten the market over the last year.
The ranking · Quality, value and trend combined
Better than 0% of Nordic stocks
- Quality11
- Value1
- Trend5
No. 195 of 195 in healthcare
Max for seven days
Follow Qlife Holding with AuroraAurora lets you know at the next report. No card.
Both with dividends. Figures as of 19 November 2026. General analysis, not personal advice.
Follow your thesis
Ask Aurora about Qlife Holding
Your first answer is free, no account needed.
Do you own Qlife Holding, or are you thinking about it?
See it next to the rest of your portfolio, or build your first one with Qlife Holding and a few more. Free, no card.
Super Stock+46.4%In short
- Qlife Holding has fallen 40.5% over the past year, including dividends.
- Overall, Qlife Holding ranks better than 0% of Nordic stocks on quality, value and trend.
- The largest fall over the past three years was 100.0%. The price is 100.0% below its peak now.
Quality, value and trend
Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.
Quality, value and trend together. Better than 0% of Nordic stocks.
No. 195 of 195 in healthcare
Low Weaker accounts than most: low profitability, high debt or uneven results.
No. 185 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50
- Debt to equityBorrowings divided by equity−10.19
- Asset turnoverSales divided by everything the company owns0.07
- Return on equityProfit divided by equity−271.6%
- Cash conversionOperating cash flow divided by profit–
The ranking is built on equity ratio, ROA and how steadily profit grows.
Low High price: buyers pay a lot today, often because they expect growth.
No. 191 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50
- P/BPrice divided by equitynegative earnings
- P/SPrice divided by sales48.5
- P/EPrice divided by earningsnegative earnings
- P/CFPrice divided by operating cash flownegative earnings
The ranking is built on P/E, P/B and P/S.
Low Headwind in the share price: it has done worse than most over the last year.
No. 176 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50
- 3 months−50.8%
- 6 months−55.2%
- 9 months−57.3%
- 12 months−40.5%
The ranking is built on 3, 6 and 12–1 months.
Return and risk
Return with dividends reinvested.
About Qlife Holding
Qlife Holding AB is a company in healthcare, listed on Nasdaq Stockholm. By market value, Qlife Holding is number 127 of 137 companies in healthcare on Nasdaq Stockholm. Qlife Holding has not paid a dividend in the past twelve months. Of the three measures in the ranking, Qlife Holding is strongest on quality, better than 11% of Nordic stocks. The share trades in SEK. It has around 2 employees.
Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents in Sweden. The company offers Egoo.Health Platform, a product platform that enables advanced biomarker testing, consisting of a small device, disposable capsules, and the supplementing software. Qlife Holding AB (publ) was incorporated in 2019 and is based in Gothenburg, Sweden.


See the full analysis of Qlife Holding.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
Free forever · No card